The Hepatic Vagus Mediates Fat-Induced Inhibition of Diabetic Hyperphagia
- 1Department of Physiology, School of Medicine, University of California, San Francisco, San Francisco, California
- 2Monell Chemical Senses Center, Philadelphia, Pennsylvania
- Address correspondence and reprint requests to Dr. Susanne E. la Fleur, Department of Physiology, School of Medicine, University of California San Francisco, 513 Parnassus Avenue, Box 0444, San Francisco, CA 94143-0444. E-mail: susanne{at}itsa.ucsf.edu
Abstract
Diabetic rats both overeat high-carbohydrate diet and have altered hypothalamic neuropeptide Y (NPY) and corticotropin-releasing factor (CRF). In contrast, a high-fat diet reduces caloric intake of diabetics to normal, reflected by normal hypothalamic NPY and CRF content. How the brain senses these changes in diet is unknown. To date, no hormonal changes explain these diet-induced changes in caloric intake. We tested whether the common branch of the hepatic vagus mediates the fat signal. We presented fat in two ways. First, diabetic and vehicle-treated rats were offered a cup of lard in addition to their normal high-carbohydrate diet. Second, we switched diabetic rats from high-carbohydrate diet to high-fat diet, without choice. In streptozotocin-treated rats, both methods resulted in fat-induced inhibition of caloric intake and normalization of hypothalamic neuropeptides to nondiabetic levels. Strikingly, common branch hepatic vagotomy (unlike gastroduodenal vagotomy) entirely blocked these fat-induced changes. Although a shift in hepatic energy status did not explain the lard-induced changes in diabetic rats, the data suggested that common hepatic branch vagotomy does not interfere with hepatic energy status. Furthermore, common branch hepatic vagotomy without diabetes induced indexes of obesity. Abnormal function of the hepatic vagus, as occurs in diabetic neuropathy, may contribute to diabetic obesity.
- AGRP, agouti-related peptide
- Arc, arcuate nucleus
- CRF, corticotropin-releasing factor
- ME, median eminence
- NPY, neuropeptide Y
- POMC, proopiomelanocortin
- PVN, paraventricular nucleus
- STZ, streptozotocin
Footnotes
-
- Received March 7, 2003.
- Revision received May 29, 2003.
- DIABETES











